Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer

S Merson; Z H Yang; D Brewer; D Olmos; A Eichholz; F McCarthy; G Fisher; G Kovacs; D M Berney; C S Foster; H Møller; P Scardino; J Cuzick; C S Cooper; Jeremy Clark; Transatlantic Prostate Group

doi:10.1038/bjc.2014.13

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer

S Merson, Z H Yang, D Brewer, D Olmos, A Eichholz, F McCarthy, G Fisher, G Kovacs, D M Berney, C S Foster, H Møller, P Scardino, J Cuzick, C S Cooper, Jeremy Clark, Transatlantic Prostate Group

Research output: Contribution to journal › Article › peer-review

26 Citations (Scopus)

Abstract

Androgen receptor (AR)-gene amplification, found in 20-30% of castration-resistant prostate cancer (CRPCa) is proposed to develop as a consequence of hormone-deprivation therapy and be a prime cause of treatment failure. Here we investigate AR-gene amplification in cancers before hormone deprivation therapy.

Original language	English
Pages (from-to)	1655-1662
Number of pages	8
Journal	British Journal of Cancer
Volume	110
Issue number	6
DOIs	https://doi.org/10.1038/bjc.2014.13
Publication status	Published - 18 Mar 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/bjc.2014.13Licence: CC BY-NC-SA

Daniel Brewer
- D.Breweruea.acuk
- Norwich Medical School - Professor in Medical Bioinformatics and Genomics
- Metabolic Health - Member
- Cancer Studies - Member
Person: Research Group Member, Research Centre Member, Academic, Teaching & Research
Colin Cooper
- Colin.Cooperuea.acuk
- Norwich Medical School - Professor of Cancer Genetics
- Cancer Studies - Member
Person: Research Group Member, Academic, Teaching & Research

Cite this

Merson, S., Yang, Z. H., Brewer, D., Olmos, D., Eichholz, A., McCarthy, F., Fisher, G., Kovacs, G., Berney, D. M., Foster, C. S., Møller, H., Scardino, P., Cuzick, J., Cooper, C. S., Clark, J., & Transatlantic Prostate Group (2014). Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer. British Journal of Cancer, 110(6), 1655-1662. https://doi.org/10.1038/bjc.2014.13

@article{b6c9b885e173417db5548060a767bd84,

title = "Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer",

abstract = "Androgen receptor (AR)-gene amplification, found in 20-30% of castration-resistant prostate cancer (CRPCa) is proposed to develop as a consequence of hormone-deprivation therapy and be a prime cause of treatment failure. Here we investigate AR-gene amplification in cancers before hormone deprivation therapy.",

author = "S Merson and Yang, {Z H} and D Brewer and D Olmos and A Eichholz and F McCarthy and G Fisher and G Kovacs and Berney, {D M} and Foster, {C S} and H M{\o}ller and P Scardino and J Cuzick and Cooper, {C S} and Jeremy Clark and {Transatlantic Prostate Group}",

year = "2014",

month = mar,

day = "18",

doi = "10.1038/bjc.2014.13",

language = "English",

volume = "110",

pages = "1655--1662",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "6",

}

Merson, S, Yang, ZH, Brewer, D, Olmos, D, Eichholz, A, McCarthy, F, Fisher, G, Kovacs, G, Berney, DM, Foster, CS, Møller, H, Scardino, P, Cuzick, J, Cooper, CS , Clark, J & Transatlantic Prostate Group 2014, 'Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer', British Journal of Cancer, vol. 110, no. 6, pp. 1655-1662. https://doi.org/10.1038/bjc.2014.13

TY - JOUR

T1 - Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer

AU - Merson, S

AU - Yang, Z H

AU - Brewer, D

AU - Olmos, D

AU - Eichholz, A

AU - McCarthy, F

AU - Fisher, G

AU - Kovacs, G

AU - Berney, D M

AU - Foster, C S

AU - Møller, H

AU - Scardino, P

AU - Cuzick, J

AU - Cooper, C S

AU - Clark, Jeremy

AU - Transatlantic Prostate Group

PY - 2014/3/18

Y1 - 2014/3/18

N2 - Androgen receptor (AR)-gene amplification, found in 20-30% of castration-resistant prostate cancer (CRPCa) is proposed to develop as a consequence of hormone-deprivation therapy and be a prime cause of treatment failure. Here we investigate AR-gene amplification in cancers before hormone deprivation therapy.

AB - Androgen receptor (AR)-gene amplification, found in 20-30% of castration-resistant prostate cancer (CRPCa) is proposed to develop as a consequence of hormone-deprivation therapy and be a prime cause of treatment failure. Here we investigate AR-gene amplification in cancers before hormone deprivation therapy.

U2 - 10.1038/bjc.2014.13

DO - 10.1038/bjc.2014.13

M3 - Article

C2 - 24481405

VL - 110

SP - 1655

EP - 1662

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 6

ER -

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer

Abstract

UN SDGs

Access to Document

Profiles

Daniel Brewer

Colin Cooper

Cite this